SCHEMBL8334682

SCHEMBL8334682

COC(=O)c1ccc(CCC(F)(F)F)c(S(C)(=O)=O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.47
EPHX2 P34913 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
CYP1A2 P05177 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
NOTUM Q6P988 2/20 0.42
KDM4E B2RXH2 2/20 0.41
HSD17B10 Q99714 1/20 0.41
SDHB P21912 1/20 0.40
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MAPT P10636 2/20 0.39
HPGD P15428 1/20 0.39
CMA1 P23946 3/20 0.39
PTGS2 P35354 1/20 0.39
POLB P06746 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8917863 0.82 VCAM1 (0.55) VCAM1SMN1; SMN2CYP1A2TSHRCYP2C19
SCHEMBL24213970 0.81 NOTUM (0.46) EPHX2CYP1A2CYP2C19NOTUMKDM4E
SCHEMBL8104315 0.80 SLC9A1 (0.56)
SCHEMBL8104313 0.79 EPHX2 (0.41) EPHX2
SCHEMBL27652105 0.79 VCAM1 (0.52) VCAM1SMN1; SMN2CYP1A2TSHRCYP2C19
SCHEMBL8894848 0.79 ALDH1A1 (0.47) VCAM1CYP1A2CYP2C19KDM4EHSD17B10
Hydrochloric Acid SCHEMBL8097803 0.79 SLC9A1 (0.55)
Hydrochloric Acid SCHEMBL8095878 0.78 EPHX2 (0.40) EPHX2
SCHEMBL8816182 0.77 VCAM1 (0.50) VCAM1SMN1; SMN2CYP1A2TSHRCYP2C19
SCHEMBL8147246 0.76 NOTUM (0.61) VCAM1SMN1; SMN2CYP1A2TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1063436-C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines, prepn. method and usage thereof HOECHST AG (DE) 2001-03-21 CN disclosed
US-5998481-A CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-12-07 US disclosed
US-5869531-A NO UNDESIREABLE SALIDIURETIC PROPERTIES; TREATING ISCHEMIA INDUCED DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1999-02-09 US disclosed
CN-1128752-A Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines, prepn. method and usage thereof HOECHST AG (DE) 1996-08-14 CN disclosed